EMPLICITI 400 mg/1
elotuzumab · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · E.R. Squibb & Sons, L.L.C.
EMPLICITI is a injection, powder, lyophilized, for solution containing elotuzumab at 400 mg/1, taken intravenous. Manufactured by E.R. Squibb & Sons, L.L.C..
Key Facts
- Brand Name
- EMPLICITI
- Generic Name
- elotuzumab
- NDC Code (Product)
0003-4522- Manufacturer
- E.R. Squibb & Sons, L.L.C.
- Strength
- 400 mg/1
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761035
- Drug Class
- SLAMF7-directed Immunostimulatory Antibody [EPC]
- Marketing Start
- 11/30/2015
Recall History
No Recall HistoryFrequently Asked Questions
What is EMPLICITI used for?
EMPLICITI contains elotuzumab. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is EMPLICITI a controlled substance?
EMPLICITI is not classified as a controlled substance by the DEA.
What is the generic name for EMPLICITI?
The generic name for EMPLICITI is elotuzumab. There are no other listed brand versions of elotuzumab.
What is the NDC code for EMPLICITI 400 mg/1?
The NDC (National Drug Code) for EMPLICITI 400 mg/1 is 0003-4522, listed by E.R. Squibb & Sons, L.L.C..
Other EMPLICITI Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)